ACS is committed to helping combat the global COVID-19 pandemic with initiatives and free resources. Learn More

L. Nathan Tumey

L. Nathan Tumey

After spending 7 years as a small molecule medicinal chemist, Nathan joined Pfizer in 2010 as part of the ADC chemistry team.  He currently leads the conjugation chemistry group, playing a critical role in the evaluation of new linker-payloads and conjugation strategies.  One particular area of interest for Nathan is ADC metabolism and biophysical stability.